Sumatriptan succinate and Valacyclovir hydrochloride drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Sumatriptan succinate (sumatriptan succinate) and Valacyclovir hydrochloride (valacyclovir hydrochloride). Common drug interactions include drug ineffective among females and inflammation among males.

The phase IV clinical study analyzes what interactions people have when they take Sumatriptan succinate and Valacyclovir hydrochloride. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Sumatriptan succinate?

Sumatriptan succinate has active ingredients of sumatriptan succinate. It is often used in migraine. eHealthMe is studying from 9,731 Sumatriptan succinate users. Check the latest studies of Sumatriptan succinate.

What is Valacyclovir hydrochloride?

Valacyclovir hydrochloride has active ingredients of valacyclovir hydrochloride. It is often used in herpes zoster. eHealthMe is studying from 12,929 Valacyclovir hydrochloride users. Check the latest studies of Valacyclovir hydrochloride.



On Jul, 11, 2026

19 people who take Sumatriptan succinate and Valacyclovir hydrochloride together, and have interactions are studied.

Sumatriptan succinate and Valacyclovir hydrochloride drug interactions.

What are the common drug interactions of Sumatriptan Succinate and Valacyclovir Hydrochloride, by gender? *:

female:

  1. Drug ineffective
  2. Fall
  3. Arthralgia (joint pain)
  4. Drug intolerance (drug sensitivity)
  5. Headache (pain in head)
  6. Limb injury
  7. Upper limb fracture
  8. Angioedema (rapid swelling of the dermis)
  9. Asthenia (weakness)
  10. Dysphonia (speech disorder attributable to a disorder of phonation)

male:

  1. Inflammation
  2. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  3. Gastrointestinal infection (infection of stomach and intestine)
  4. Headache (pain in head)
  5. Hypersensitivity
  6. Immunisation reaction
  7. Infusion site haemorrhage (bleeding from infusion site)
  8. Infusion site pain
  9. Muscle strain (an injury to a muscle in which the muscle fibres tear)
  10. Nausea (feeling of having an urge to vomit)

What are the common drug interactions of Sumatriptan Succinate and Valacyclovir Hydrochloride, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Abnormal behaviour
  2. Allergy to metals
  3. Dizziness
  4. Drug ineffective
  5. Drug intolerance (drug sensitivity)
  6. Herpes virus infection
  7. Memory impairment
  8. Nightmare (unpleasant dream)
  9. Rhinitis allergic (inflammation of the nasal airways due to allergy)
  10. Sinusitis (inflammation of sinus)

30-39:

n/a

40-49:

  1. Drug ineffective
  2. Fall
  3. Limb injury
  4. Upper limb fracture
  5. Angioedema (rapid swelling of the dermis)
  6. Arthralgia (joint pain)
  7. Asthenia (weakness)
  8. Drug intolerance (drug sensitivity)
  9. Dysphonia (speech disorder attributable to a disorder of phonation)
  10. Fatigue (feeling of tiredness)

50-59:

  1. Drug ineffective

60+:

  1. Asthma
  2. Cough
  3. Headache (pain in head)
  4. Hypersensitivity
  5. Immunisation reaction
  6. Influenza
  7. Infusion site haemorrhage (bleeding from infusion site)
  8. Infusion site pain
  9. Muscle strain (an injury to a muscle in which the muscle fibres tear)
  10. Nausea (feeling of having an urge to vomit)

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 8 people, 42.11%
  2. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 6 people, 31.58%
  3. Drowsiness: 5 people, 26.32%
  4. Angioedema (rapid swelling of the dermis): 2 people, 10.53%
  5. Pain: 2 people, 10.53%
  6. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 10.53%
  7. Stress And Anxiety: 1 person, 5.26%
  8. Lipodystrophy Acquired (a regional loss of subcutaneous adipose tissue which usually starts in the face, extends downward acquired): 1 person, 5.26%
  9. Blood Pressure Abnormal: 1 person, 5.26%
  10. Depression: 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Sumatriptan succinate and Valacyclovir hydrochloride?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Sumatriptan succinate and Valacyclovir hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Sumatriptan succinate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Valacyclovir hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Sumatriptan succinate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Valacyclovir hydrochloride and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on sumatriptan succinate and valacyclovir hydrochloride (the active ingredients of Sumatriptan succinate and Valacyclovir hydrochloride, respectively), and Sumatriptan succinate and Valacyclovir hydrochloride (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: